Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Secondary malignant neoplasm of lymph node
0.070 AlteredExpression disease BEFREE High expression of LAPTM4B-35 in lymph node metastasis was found in 29.2% of cases. 31827181 2019
Secondary malignant neoplasm of lymph node
0.070 AlteredExpression disease BEFREE VEGF and nuclear survivin expression was significantly correlated with LAPTM4B expression, and high levels of all three were associated with a tumor size >2cm, TNM stage II+III and lymph node metastasis, which had worse impacts on overall survival and progression-free survival in breast cancer patients. 28476037 2017
Secondary malignant neoplasm of lymph node
0.070 AlteredExpression disease BEFREE Immunohistochemical staining demonstrated that high expression level of LAPTM4B was independently associated with axillary lymph node metastasis (odds ratio=2.428; 95%CI=1.333- 4.425; P=0.004). 28245476 2017
Secondary malignant neoplasm of lymph node
0.070 AlteredExpression disease BEFREE Combined LAPTM4B-35 and VEGF expression was significantly associated with FIGO stage (P = 0.014), tumor histologic grade (P = 0.033), lymph node metastasis (P = 0.045), and recurrence (P = 0.010). 26526574 2016
Secondary malignant neoplasm of lymph node
0.070 Biomarker disease BEFREE LAPTM4B *1/1 was more frequently detected in colon cancer patients with lymph node metastasis and TNM III+IV stages in total colon cancer (discovery + testing cohorts). 27391361 2016
Secondary malignant neoplasm of lymph node
0.070 AlteredExpression disease BEFREE As a result, age, tumor number, primary tumor category, histological type, histological growth pattern, and LAPTM4B-35 protein expression were found to be significantly related to lymph node metastasis (P = 0.010, 0.001, 0.032, 0.001, 0.001, and 0.001, respectively). 25416438 2014
Secondary malignant neoplasm of lymph node
0.070 Biomarker disease BEFREE LAPTM4B*2 was significantly associated with higher histopathologic grade, lymph node metastasis and poor prognosis. 22984585 2012